David Sassoon is the founder and publisher of InsideClimate News, the nonpartisan and nonprofit news organization that won the Pulitzer Prize for National Reporting in 2013. He has been a writer, editor and publisher for 25 years, involved with public interest issues, including human rights, cultural preservation, healthcare, education and the environment. In 2003, he began researching the business case for climate action for the Rockefeller Brothers Fund. As an outgrowth of his research, Sassoon founded a blog in 2007 that has grown and evolved into InsideClimate News. He earned his undergraduate degree from Harvard University and a master’s degree from Columbia University’s Graduate School of Journalism. He is the author of “Tiny Specks in a Hurry: The Story of a Journey to Mustang.”
![](https://www.thetransmitter.org/wp-content/uploads/2015/08/David-Sassoon200.jpg)
David Sassoon
Publisher
InsideClimate News
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.